NCT02222220View on ClinicalTrials.gov

Metoclopramide as Treatment of Clozapine-induced Hypersalivation

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Clozapine-induced Hypersalivation
Interventions
DRUG

Metoclopramide

30 mg/day during 4 weeks

DRUG

placebo

Trial Locations (1)

8417000

Be'er Sheva Mental Health Center,, Beersheba

All Listed Sponsors
collaborator

Tirat Carmel Mental Health Center

OTHER_GOV

lead

Beersheva Mental Health Center

OTHER_GOV

NCT02222220 - Metoclopramide as Treatment of Clozapine-induced Hypersalivation | Biotech Hunter | Biotech Hunter